Elanco Animal Health Incorporated
ELAN
$17.96
-$0.04-0.22%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.24B | 1.19B | 1.02B | 1.03B | 1.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.24B | 1.19B | 1.02B | 1.03B | 1.18B |
| Cost of Revenue | 528.00M | 509.00M | 501.00M | 492.00M | 495.00M |
| Gross Profit | 713.00M | 684.00M | 519.00M | 538.00M | 689.00M |
| SG&A Expenses | 400.00M | 341.00M | 294.00M | 323.00M | 354.00M |
| Depreciation & Amortization | 136.00M | 128.00M | 130.00M | 133.00M | 131.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16B | 1.07B | 1.01B | 1.04B | 1.07B |
| Operating Income | 85.00M | 121.00M | 14.00M | -5.00M | 115.00M |
| Income Before Tax | 25.00M | 60.00M | -51.00M | 559.00M | -32.00M |
| Income Tax Expenses | 14.00M | -7.00M | -43.00M | 195.00M | 18.00M |
| Earnings from Continuing Operations | 11.00M | 67.00M | -8.00M | 364.00M | -50.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.00M | 67.00M | -8.00M | 364.00M | -50.00M |
| EBIT | 85.00M | 121.00M | 14.00M | -5.00M | 115.00M |
| EBITDA | 246.00M | 273.00M | 138.00M | 165.00M | 267.00M |
| EPS Basic | 0.02 | 0.14 | -0.02 | 0.74 | -0.10 |
| Normalized Basic EPS | 0.03 | 0.09 | -0.06 | -0.08 | 0.06 |
| EPS Diluted | 0.02 | 0.13 | -0.02 | 0.73 | -0.10 |
| Normalized Diluted EPS | 0.03 | 0.09 | -0.06 | -0.08 | 0.06 |
| Average Basic Shares Outstanding | 496.60M | 495.10M | 494.40M | 494.30M | 494.20M |
| Average Diluted Shares Outstanding | 500.10M | 499.10M | 494.40M | 497.70M | 494.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |